Download Read More - Star State Heart

CURRICULUM VITAE
Samuel J. DeMaio, MD Page !1
CURRICULUM VITAE
SAMUEL J. DEMAIO, MD
Office Address:
Star State Heart, P.L.L.C.
d/b/a/Star State Heart & Vascular, P.L.L.C.
200 Medical Pkwy, Suite 270
Lakeway, TX 78738
Date of Birth:
January 5, 1957 (Newark, NJ)
EDUCATION
1975-1979
B.S.E.E. - High Honors: Rutgers College of Engineering (New Brunswick, NJ)
Sept.79-May 83
M.D.: UMDNJ - New Jersey Medical School (Newark, NJ)
July 83-June 84
Internship - Internal Medicine: Baylor University (Dallas, TX)
John S. Fordtran, M.D., Chief
July 84-June 86
Residency - Internal Medicine: Baylor University (Dallas, TX)
John S. Fordtran, M.D., Chief
July 86-June 89
Fellowship - Cardiology: Emory University (Atlanta, GA)
R. Wayne Alexander, M.D., PhD., Chief
Jan.89-June 89Fellowship - Electrophysiology: Emory University (Atlanta, GA)
Paul F. Walter, M.D.
July 89-June 90
Fellowship - Interventional Cardiology: Emory University (Atlanta, GA)
Spencer B. King, III, M.D., Chief
July-Sept 1990
Fellowship - Interventional Cardiology (Peripheral Vascular Disease):
University of Munich (Six weeks)
Berthold Hoefling, M.D., Chief
1994-May 1999
J.D.: Southern Methodist University School of Law (Dallas, TX).
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !2
EMPLOYMENT
Medical:
2012 – Present
Star State Heart, P.L.L.C.
d/b/a/Star State Heart & Vascular, P.L.L.C.
200 Medical Pkwy, Suite 270
Lakeway, TX 78738
2012 – 2012
Star State Heart, P.L.L.C.
d/b/a/Star State Heart & Vascular, P.L.L.C.
1008 RR 620 South, Suite 250
Austin, TX 78734
2010 – 2012
Star State Heart, P.L.L.C.
d/b/a/Star State Heart & Vascular, P.L.L.C.
1400 George Dieter Drive, Suite 110
El Paso, TX 79936
2009-2010
Capital Cardiovascular Consultants, P.L.L.C.
d/b/a/Capital Cardiovascular Specialists, P.L.L.C.
(Group formerly known as Austin Cardiovascular Associates)
1400 George Dieter Drive
El Paso, TX 79936
2002-2010
Capital Cardiovascular Consultants, P.L.L.C.
d/b/a/Capital Cardiovascular Specialists, P.L.L.C.
(Group formerly known as Austin Cardiovascular Associates)
4207 James Casey; Suite 215; Austin, TX 78745
512-445-5998
2001-2002
Austin Cardiovascular Associates
4207 James Casey; Suite 215; Austin, TX 78745
512-445-5998
1990-2001
Texas Cardiology Consultants
712 N. Washington; Suite 300; Dallas, TX 75249-1633
(214) 824-8721
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !3
1993-1994
Law:
2002 to Present
1999-2002
HOSPITAL
AFFILIATIONS:
Assistant Editor, American Journal of Cardiology
Girards Law Firm
10000 North Central Expressway, Ste 750
Dallas, TX 75231
Inactive
Buchholz, Sassin and DeMaio
325 N. St. Paul; 4000 Republic Center Tower II
Dallas, TX 75201
Lakeway Regional Medical Center (2012-present)
100 Medical Pkwy
Lakeway, Texas 78738
East El Paso Physicians Medical Center (2009-2012)
1400 George Dieter
El Paso, Texas
Chief of Cardiology
Lakeside Hospital at Bastrop (2006-2009)
3201 Highway 71 East
Bastrop, TX 7802
Heart Hospital of Austin (2002-2009)
3801 North Lamar Boulevard
Austin, TX 78756
Daughters of Charity Health Services of Austin
d/b/a Seton Medical Center (2002-2009)
1201 West 38th Street; Austin, TX 78705
South Austin Hospital (2001- 2/2009)
901 West Ben White Boulevard; Austin, TX 78745
Director of Cardiac Cath Lab and Interventional Cardiology (2004)
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !4
The Hospital at Westlake Medical Center (2005-2008)
Director of Cardiology
Member of Medical Executive Committee
5656 Bee Cave Road M-302
Austin, TX 78746
Baylor University Medical Center (1992-2001)
3500 Gaston Avenue; Dallas, TX 75246
St. Paul Medical Center (1992-2001)
5909 Harry Hines Blvd.; Dallas, TX 75235
HONORS:
1977: Tau Beta Pi - National Engineering Honor Society
1977: Eta Kappa Nu - National Electrical Engineering Honor Society
1983: Alpha Omega Alpha - Medical Honor Society
2011: American Academy of Nurse Practitioners – State Award for Excellence
FELLOWSHIP/
MEMBERSHIP:
Fellow - American College of Cardiology
Fellow - American College of Physicians
Fellow - Society of Cardiovascular Angiography and Interventions
American Medical Association
American Heart Association
American College of Chest Physicians
North Texas Cardiovascular Society - President 1993
CERTIFICATION:
Diplomate - National Board of Medical Examiners, #274922, March 1984
Diplomate - American Board of Internal Medicine, #106453, September 1986
Diplomate - ABIM - Cardiovascular Disease, #106453, November 1989
North American Society of Pacing and Electrophysiology - Special
Competency,
Cardiac Pacing, September 1991
Diplomate - ABIM - Interventional Cardiology, 1999.
Diplomate-Recertification –ABIM- Interventional Cardiology, October 2009.
LICENSES:
Revised March 2016
Legal:
State of Texas Bar #24012519
State of Arkansas Bar #2000 063
Medical:
State of Texas #G6655
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !5
State of Georgia #028157 (inactive)
BIBLIOGRAPHY
Papers and Chapters Published:
1.
Haft JI, DeMaio SJ, Bartoszyk OB: The coronary arteriographic findings in symptomatic patients
with right bundle branch block. Am J Cardiol 1984; 53:770-773.
2.
DeMaio SJ, Dinsella SH, Silverman ME: Clinical course and long-term prognosis of spontaneous
coronary artery dissection. Am J Cardiol 1989; 64:471-474.
3.
DeMaio SJ, Walter PF, Crawley SI: Cardiac arrhythmias: Their identification and management. In:
The Emory University Comprehensive Board Review in Internal Medicine. Presented in Atlanta,
GA on August 3, 1989.
4.
DeMaio SJ: Sudden cardiac death. In: Schlant RC, Hurst JW (eds), The Heart, 7th Companion
Handbook, New York, McGraw Hill Inc., 1990; 6:56-60.
5.
DeMaio SJ, Walter PF, Douglas JS: Treatment of ventricular tachycardia induced cardiogenic
shock by percoronary chemical ablation. Cath and Cardiovasc Diag 1990; 21:170-176.
6.
DeMaio SJ: Surgical and catheter ablative therapy of ventricular arrhythmias. In: Hurst JW (Ed),
Current Therapy in Cardiovascular Disease -3, Philadelphia, B.C. Decker, Inc., 1991.
7.
DeMaio SJ: Surgical and catheter ablative therapy of supraventricular arrhythmias. In: Hurst JW
(Ed), Current Therapy in Cardiovascular Disease-3, Philadelphia, C.B. Decker Ind., 1991.
8.
Hearn JA, DeMaio SJ, Roubin GS, Hammarstrom M, Sgoutas DS: Predictive value of lipoproteins
in the angiographic diagnosis of coronary artery disease. Am J Cardiol 1990; 66:1176-1180.
9.
Bauriedel G, DeMaio SJ, Hoefling B: The role of angioscopy in the treatment of peripheral
vascular disease with percutaneous atherectomy. Am J Cardiol 1991; 68:226-231.
10.
Bauriedel G, Windsetter U, DeMaio SJ Kandolf R, Hoefling B: Human coronary and peripheral
arterial smooth muscle cell activity in primary and restenotic lesions obtained by percutaneous
atherectomy. Circulation 1992; 85:554-564.
11.
DeMaio SJ, King III SB, Lembo NJ, Roubin GS, Hearn JA, Bhagavan HN, Sgoutas DS: Vitamin E
supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal
coronary
angioplasty (PTCA). J of the Am Col of Nutrition 1992; Vol. II, No. 1, 68-73.
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !6
12.
Bauriedel G, DeMaio SJ, Hoefling B: Sheath introducer technique for recanalizing total occlusions
of the superficial femoral artery. Cath and Cardiovasc Diag 1992; 25:66-70.
13.
DeMaio SJ, Stocker E: Surgical and catheter ablative therapy of ventricular arrhythmias. In: Hurst
JW (Ed), Current Therapy in Cardiovascular Disease-4, Philadelphia, B.C. Decker Inc., 1994.
14.
DeMaio SJ, Stocker E: Surgical and catheter ablative therapy of supraventricular arrhythmias. In:
Hurst JW (Ed), Current Therapy in Cardiovascular Disease-4, Philadelphia, B.C. Decker Inc.,
1994.
15.
Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King SB, Ivanhoe R, Cedarholm JC,
Stillabower ME, Talley JD, Samuel J. De Maio, Robbins DC, Brown CL, Alexander RW, and the
Lovastatin Restenosis Trial Study Group: Lack of effect of Lovanstatin on restenosis after
coronary angioplasty. N Engl J Med 1994; 1331:1331-7.
16.
Richard O. Han, MDa, Robert S. Schwartz, MDb, Yoshiki Kobayashi, MDh, Stephanie H. Wilson,
MD, J.Tift Mann, MDc, Michael H. Sketch, MDd, Robert D. Safian, MDe, Alexandra Lansky,
MDf, Jeffrey Popma, MDg, Peter J. Fitzgerald, MD, PhDh, Igor F. Palacios, MDa,
Marilyn Chazin-Caldie, MSi, Sheldon Goldberg, MD, For the Stent COmparative REStenosis
(SCORES) Trial Investigators Comparison of self-expanding and balloon-expandable stents for
the reduction of restenosis Am. J. Card. 2001: 88(3), p253-259. (Principle Investigator—Dallas).
17.
Rothenberg, F, Franklin, JO, DeMaio, SJ. Use, value, and toxicity of amiodarone. Heart Dis
Stroke ;2004: 3:19-23
20.
Harvey, LAC, DeMaio SJ, Roberts, WC: Radiation-induced cardiovascular disease including
stenosis of coronary ostium, coronary and carotid arteries, and aortic valve. BUMC Proceedings
1994:7(3):33-36.
20.
Perin, EC, DeMaio, SJ, George, B, O’Neill, WW. Percutaneous laser revascularization in patients
with chronic total occlusions. Letter to the Editor. J Am Coll Cardiol, 2002; 40:2062.
21.
Whitlow PL, DeMaio SJ Jr, Perin EC, O'Neill WW, Lasala JM, Schneider JE, McKeever LS,
Ezratty AM, Knopf WD, Powers ER, Shawl FA; Eclipse Investigators. One-year results of
percutaneous myocardial revascularization for refractory angina pectoris. Am J Card. 2003;91(11):
1342-6.
22.
Moses, J, et. al., Sirolimus-Eluting Stents versus Standards Stents in Patients with Stenosis in a
Native Coronary Artery. N. Eng. J. Med. 2003; 349(14) p.1315-1323. (Principle Investigator—
Dallas. Baylor University Medical Center).
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !7
23.
David R Holmes, Jeffrey Moses, Martin Leon, Mark Midei, Michael Mooney, Donald Baim,
Samuel De Maio, Jeffrey Popma, Richard Kuntz. Sirolimus versus plain old balloon angioplasty
small vessels. Journal of the American College of Cardiology. 3 March 2004 (Vol. 43, Issue 5,
Supplement 1, Page A35) 24.
Stone, Greg, et.al., A Polymer-Based, Pactlitaxel-Eluting Stent in Patents with Coronary Artery
Disease. N. Eng. J. Med. 2004; 350(3):221-131. (Principle Investigator—Austin, Texas).
25.
Sawhney, N Moses, JW, Leon MB, Kuntz RE, Popma, JJ, Bachinsky, W, Bass, T, DeMaio, SJ, Fry,
E Holmes, DR Jr, Teirstein, PS. Treatment of left anterior descending coronary artery disease with
sirolimus-eluting stents. Circulation; 2004 July 27;110(4):374-9.
26.
Gregg W. Stone, M.D., Stephen G. Ellis, M.D., David A. Cox, M.D., James Hermiller, M.D.,
Charles O'Shaughnessy, M.D., James Tift Mann, M.D., Mark Turco, M.D., Ronald Caputo, M.D.,
Patrick Bergin, M.D., Joel Greenberg, M.D., Jeffrey J. Popma, M.D., Mary E. Russell, M.D., for
the TAXUS-IV Investigators: A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary
Artery Disease. N. Eng. J. Med. 2004; 330; p221-231 (Principle Investigation—Austin)
27.
Drenth, D, Zijlstra, F, Boonstra, PW, Sawhney, N, Teirstein, PS, Moses, JW, Leon, MB, Kuntz, RE
Popma, JJ, Bachinsky, W, Bass, T, DeMaio, SJ, Fry, E, Holmes, DR,Jr. Letter Regarding Article by
Sawhney et al, "Treatment of Left Anterior Descending Coronary Artery Disease With SirolimusEluting Stents” Response. Circulation, Apr 2005; 111: e265 - e266.
28.
Stone, Gregg W., DeMaio, Samuel, et. al: Comparison of a Polymer-Based Paclitaxel-Eluting Stent
with a Bare Metal Stent in Patients with Complex Coronary Artery Disease. TAXUS V
Investigators. JAMA; September 14, 2005: 294 (10): 1215-23.
29.
Stephen G. Ellis, Samuel DeMaio, et. al.: Final 5Year Outcomes from the TAXUS V de novo
Trial: LongTerm Safety and Effectiveness of the PaclitaxelEluting TAXUS Stent in Complex
Lesions. Am J Cardiol. 2009;104(suppl):135D. Presented TCT 365 (2009).
Abstracts Published
1.
Haft JI, DeMaio SJ, Schlanger LI: Left ventricular ejection fraction abnormalities in patients with
mitral valve prolapse. Clin Research 1981; 19(2):202A.
2.
Hearn JA, DeMaio SJ, Roubin GS, Hammarstrom M, Sgoutas DS: Apolipoproteins, Lp(a), and
lipids in the prediction of coronary artery disease. Arteriosclerosis 1989;9:(5):739a.
3.
Bauriedel G, Ganesh S, Heidemann P, Heimeri J, DeMaio SJ, Kandolf R, Hoefling B: Concordant
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !8
anti-proliferative and anti-migratory effects of cardiovascular drugs on human plaque smooth
muscle cells. Am J Cardiol 1992; 19:3:suppl A.
4.
Moses, Jeffery W. for the SIRIUS Principal Investigators: Sirolimus-eluting Stents versus Standard
Stents in Patients with Stenosis in a Native Coronary Artery. New England Journal of Medicine
2003; 349(14).
5.
Kereiakes, Dean J. for the AMEthyst Principal Investigators: A Novel Filter-Based Distal Embolic
Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions. JACC:
Cardiovascular Interventions 2008; Vol.1, No. 3.
MEDICAL ADVISORY BOARDS
1.
SCI-MED/Boston Scientific Medical Advisory Board: 1990-2007.
2.
SCI-Med/Peripheral Vascular Advisory Board: 1998 - 2007.
3.
Bard/St. Jude Cardiac Assist-Intravascular Advisory Board: 1994-1998.
4.
Medtronic/ AVE, President Advisory Board-Coronary and Peripheral Angioplasty - 1999-2006.
5.
Baylor PTCA (Percutaneous Transluminal Coronary Angioplasty) Task Force: Chairman
1994-1996.
6.
Cordis Corporation: Coronary and Peripheral Medical Advisory Board: 1999-2007.
PATENTS
U.S. Patent #5540798: Durphy-DeMaio Ulti-Cath. (angioplasty balloon catheter)
HDE DEVICES
1.
2.
3.
JOSTENT Coronary Stent Graft. IRB# 02-06-03.
CardioSEAL Septal Occlusion System for PFO Closure. IRB # 03-05-07.
Amplatzer PFO Occluder (ASD Occluder certified). IRB # 04-01-05.
COMPLETED RESEARCH
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !9
1.
SCIMED Big Skinny Percutaneous Transluminal Coronary Angioplasty Catheter. IRB# 091-022.
86821216.
Drug-Eluting Collar on Standard Telectronics Lead. IRB# 091-023.
3.
A Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of
Lovastatin on the Prevention of Coronary Restenosis Following Percutaneous Transluminal
Coronary Angioplasty. IRB# 091-053.
4.
Cost-Effectiveness of Lovastatin in the Prevention of Restenosis After Percutaneous Transluminal
Coronary Angioplasty. IRB# 091-106.
5.
SCIMED RALLY Percutaneous Transluminal Coronary Angioplasty Catheter. IRB# 092-019.
6.
Coronary Thrombolysis in Patients with Acute Myocardial Infarction, Multicenter Study with
Prourokinase (FCE 26177) and t-PA Co-Administration. IRB# 092-087.
7.
Quality of Life Substudy of the Lovastatin Restenosis Trial. IRB# 092-104.
8.
The Role of Percutaneous Angioscopy in Detecting and Treating Occlusive Disease in Saphenous
Vein Grafts. IRB# 092-120.
9.
A Randomized, Open-Label Parallel Study to Evaluate the Effects of Fluosol on Complications,
Duration of Hospital Stay, and Left Ventricular Function in Coronary Angioplasty Patients at High
Risk of Hemodynamic Deterioration. IRB# 093-039.
10.
Myocardial Infarction Cost Study. IRB# 093-047.
11.
FIRST (Five Year Required Surveillance Trial) Intracoronary Stenting Using 20 mm Long Stainless
Steel Gianturco-Roubin Flex-Stent® for Acute or Threatened Closure PMA#910030.
IRB# 094-105.
12.
SCIMED Biomaterials Procurement Program, IRB# 094-108.
13.
Stent Anti-thrombotic Regimen Study Protocol- STARS Trial, IRB# 095-068.
14.
SCIMED LC-60 PTCA Catheter Investigational Plan, IRB# 096-025.
15.
SCIMED Stent Comparative Restenosis Trial - SCORES Trial, IRB# 096-047.
16.
The Study of the Safety and Effectiveness of Percutaneous Transluminal Myocardial
Revascularization in Patients with Class III or IV Angina -Phase II, IRB# 097-089. Sponsor: Eclipse
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !10
Surgical Technologies, Inc.
17.
The Palmaz-Schatz® MiniCrown Balloon Expandable Stent with the PowerGripTM Over-The-Wire
Stent Delivery System for Treatment of Abrupt or Threatened Vessel Closure, IRB# 098-055.
18.
Cordis Velocity Abrupt or Threatened Vessel Closure, #P99-4201.
19.
Medtronic AVE Predict Trial for Primary Stenting - Randomized, IRB# 099-088.
20.
Medtronic AVE Saphenous Vein Graft (SVG) Registry Trial. IRB# 099-126
21.
The Sirolimus-Coated Bx-Velocity Balloon-Expandable Stent in the treatment of patients with denovo native coronary artery lesions. The SIRIUS Trial. IRB #001-004.
22.
A multicenter trial of localized radiation therapy to inhibit restenosis. GAMMA V. IRB# 000-057.
87523216.Cilostazol for restenosis trial. CREST. IRB#01-12-02
87523217.Medtronic SAVE PACe Study evaluating the Search AV Extension for promoting Atrioventricular
Conduction. IRB# 03-05-01.
87523218.Medtronic AVE MAVErIC II Trial to evaluate the carotid stent system with distal protection in
Carotid Arteries. IRB# 03-02-03.
87523219.Emboshield and Xact Post Approval Carotid Stent Trial using the Emboshield BareWire Rapid
Exchange Embolic and Xact Rapid Exchange Carotid Stent System- The EXACT Study. IRB #
06-02-03.
87523220.The Assessment of the Medtronic AVE Interceptor Saphenous Vein Graft Filter Systems
AMEthyst Trial. IRB # 04-02-02.
87523221.A Phase II Evaluation of the Safety and Efficacy of the TriVascular ENOVUS Stent Graft System
in the Treatment of Abdominal Aortic Aneurysms. IRB #05-04-02- Study Halted prior to initiation
87523072.A prospective, randomized trial evaluating TAXUS SR Paclitaxel-eluting primary stent in denovo
coronary lesions. TAXUS IV. IRB#01-12-03.
87523073.The Sirolimus- Eluting 4.0mm Bx Velocity Balloon Expandable Stent in the treatment of patients
with de-novo coronary lesions. SIRIUS 4.0. IRB# 03-07-02.
87523074.A randomized trial evaluating the TAXUS SR Paclitaxel- Eluting Coronary Stent in the treatment
Revised March 2016
CURRICULUM VITAE
Samuel J. DeMaio, MD Page !11
of high risk lesions. TAXUS V- DENOVO. IRB # 03-02-01.
87523075.A randomized trial evaluating the TAXUS SR Paclitaxel-Eluting Coronary Stents in the treatment
of In-stent Restenosis. TAXUS V- ISR. IRB # 03-09-02.
87523076.Medtronic AVE MAVErIC III Trial evaluating the carotid stent system with distal protection
using the Interceptor PLUS Filter system. MAVErIC III. IRB #04-10-04.
87523077.A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary
stent Versus the TAXUS Paclitaxel-Eluting Coronary Stent System in DeNovo Native coronary Artery
Lesions. ENDEAVOR IV. IRB # 05-05-01.
87523078.Asymptomatic Carotid Stenosis, Stenting versus Endarterectomy Trial- ACT 1 Study.
IRB # 06-07-02.
87523079.Carotid Stenting for High surgical risk patients: Evaluating Outcomes through the collection on
Clinical Evidence. CHOICE. IRB # 07-02-02.
87523080.A Prospective, Single-Blind, Randomized, Multicenter, Study Comparing the CYPHER ELITE
And The CYPHER Bx VELOCITY Sirolimus-Eluting Stent Systems. ELITE. IRB # 07-09-02.
87523081.Gauging Responsiveness with a VERIFYNOW Assay - Impact on Thrombosis and Safety.
GRAVITAS. IRB # 08-05-01.
87523082.A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent
System in the Treatment of De Novo Native Lesions in Native Coronary Arteries with a Reference
Vessel Diameter of 2.25mm to 4.2mm. RESOLUTE. IRB # 08-09-05.
87523083.XIENCETM V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study.
XIENCE V. IRB # 08-11-06.
Revised March 2016